Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Not yet recruiting × disitamab vedotin × Clear all

Phase

Phase 2 8 Phase NA 1 Phase 4 1 Phase 2/3 1 Phase 1/2 1

Status

Recruiting 3 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Bevacizumab 14 Injections 11 Drug Therapy 10 Gemcitabine 8 tislelizumab 6 irinotecan sucrosofate 6 Temozolomide 6 Paclitaxel 6 Oxaliplatin 6 Cyclophosphamide 6 Biopsy 6 pembrolizumab 5 Magnetic Resonance Spectroscopy 5 Leucovorin 5 Fluorouracil 5 Carboplatin 5 130-nm albumin-bound paclitaxel 5 venetoclax 4 toripalimab 4 lenvatinib 4 fludarabine 4 Specimen Handling 4 Radiotherapy 4 HMPL-013 4 Etoposide 4 Dexamethasone 4 Cisplatin 4 trametinib 3 sintilimab 3 enzalutamide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06957561 2025-05-04

DIVON

Sun Yat-sen University

Phase 1/2 Not yet recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡